The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Piperacillin and Tazobactam and Sodium Chloride
Piperacillin and Tazobactam and Sodium Chloride · TAZOBACTAM SODIUM 250 mg/50mL; PIPERACILLIN SODIUM 2 g/50mL · Injection, Solution · Intravenous · B. Braun Medical Inc.
NDC 00264-3446-11 · 24 CONTAINER in 1 CASE / 50 mL in 1 CONTAINER · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$17.59
Reported to Texas DSHS · 2026 annual filing · B. Braun Medical Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 1.125 GM
$1.218
HCPCS J2543 · Jul 1, 2026 quarter · typically ASP + 6%
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA206056
- TE code
- —
- Approval date
- Apr 3, 2025
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Piperacillin and Tazobactam and Sodium Chloride (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| B. Braun Medical Inc. | TAZOBACTAM SODIUM 500 mg/100mL; PIPERACILLIN SODIUM 4 g/100mL | Aug 26, 2026 | Sep 2, 2026 |
| B. Braun Medical Inc. | TAZOBACTAM SODIUM 250 mg/50mL; PIPERACILLIN SODIUM 2 g/50mL | Aug 26, 2026 | Sep 2, 2026 |
| B. Braun Medical Inc. | TAZOBACTAM SODIUM 375 mg/50mL; PIPERACILLIN SODIUM 3 g/50mL | Aug 26, 2026 | Sep 2, 2026 |
| B. Braun Medical Inc. | TAZOBACTAM SODIUM 2 g/50mL; PIPERACILLIN SODIUM 250 mg/50mL | Jul 22, 2026 | Aug 19, 2026 |
| B. Braun Medical Inc. | TAZOBACTAM SODIUM 4 g/100mL; PIPERACILLIN SODIUM 500 mg/100mL | Jul 22, 2026 | Aug 19, 2026 |
| B. Braun Medical Inc. | TAZOBACTAM SODIUM 3 g/50mL; PIPERACILLIN SODIUM 375 mg/50mL | Jul 22, 2026 | Aug 19, 2026 |
| B. Braun Medical Inc. | PIPERACILLIN SODIUM 2 g/50mL; TAZOBACTAM SODIUM 250 mg/50mL | Jul 15, 2026 | Jul 15, 2026 |
| B. Braun Medical Inc. | PIPERACILLIN SODIUM 3 g/50mL; TAZOBACTAM SODIUM 375 mg/50mL | Jul 15, 2026 | Jul 15, 2026 |
| B. Braun Medical Inc. | PIPERACILLIN SODIUM 4 g/100mL; TAZOBACTAM SODIUM 500 mg/100mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Piperacillin and Tazobactam and Sodium Chloride — NDC 00264-3446-11," retrieved September 3, 2026, https://drugdashboards.com/drug/00264344611.
Free to cite with attribution — see how the data is put together.